Cargando…
B cell linker protein (BLNK) is a regulator of Met receptor signaling and trafficking in non-small cell lung cancer
Met is an oncogene aberrantly activated in multiple cancers. Therefore, to better understand Met biology and its role in disease we applied the Mammalian Membrane Two-Hybrid (MaMTH) to generate a targeted interactome map of its interactions with human SH2/PTB-domain-containing proteins. We identifie...
Autores principales: | Pathmanathan, Shivanthy, Yao, Zhong, Coelho, Paula, Valla, Robert, Drecun, Luka, Benz, Caroline, Snider, Jamie, Saraon, Punit, Grozavu, Ingrid, Kotlyar, Max, Jurisica, Igor, Park, Morag, Stagljar, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646953/ https://www.ncbi.nlm.nih.gov/pubmed/36388990 http://dx.doi.org/10.1016/j.isci.2022.105419 |
Ejemplares similares
-
Fundamentals of protein interaction network mapping
por: Snider, Jamie, et al.
Publicado: (2015) -
Identification of CMTM7 as a Transmembrane Linker of BLNK and the B-Cell Receptor
por: Miyazaki, Atsuko, et al.
Publicado: (2012) -
Systematic Identification of Oncogenic EGFR Interaction Partners
por: Petschnigg, Julia, et al.
Publicado: (2017) -
Split Intein-Mediated Protein Ligation for detecting protein-protein interactions and their inhibition
por: Yao, Zhong, et al.
Publicado: (2020) -
Met–HER3 crosstalk supports proliferation via MPZL3 in MET-amplified cancer cells
por: Stern, Yaakov E., et al.
Publicado: (2022)